No association between antiepileptic drug use and dementia
Antiepileptic drugs have been found to have no association with dementia, with researchers looking at the data of over 50,000 patients...
List view / Grid view
Antiepileptic drugs have been found to have no association with dementia, with researchers looking at the data of over 50,000 patients...
A collaboration between Brigham and Women's Hospital and Vanderbilt University Medical Center looks to advance the application of AI in health...
Innovations in drug manufacturing could result in higher quality drugs at less of the cost, and the FDA is willing to help facilitate this development...
The SMC has approved a drug, called rivaroxaban, that targets Factor Xa to treat those with coronary artery disease (CAD)...
Researchers have identified a method of improving the performance of infrared imaging techniques which could be useful in medical applications...
A compressed injection pill could be the future alternative to injections of insulin delivery for patients with type 2 diabetes...
The FDA has approved the first specific therapy for the rare blood clotting disorder, acquired thrombotic thrombocytopenic purpura (aTTP)...
Researchers have launched a large virtual docking library expected to grow to more than one billion molecules by 2020 which could aid drug discovery...
The antidepressant drug, trazodone, taken for anxiety and depression, has been found not to be linked to a reduced risk of dementia...
PharmaFluidics NV is a game-changing innovator in the field of analytical chromatography. The company has devised a fundamentally new way of performing separations by creating nano-LC columns on a silicon chip...
The VITAL project addresses the challenges to medicines for the ageing population, with millions in grants and sponsors going into research...
Treatments for psoriasis could help prevent heart disease in patients with the skin condition, with patients having an 8 percent reduction in their risk...
Amlodipine is an angioselective calcium channel blocker used to treat high blood pressure, chest pain and other conditions caused by coronary artery disease.
The FDA has issued a statement to promote the development of complex generic drugs to ensure access for patients and healthy drug competition...
A number of drugs currently in their late stages in the development process could see competition for nusinersen, the only current SMA treatment, rise...